A New Frontier For Psilocybin Therapy? Standardized but NOT Synthetic

If you wanted to do clinical trials for psilocybin, you generally have two options: synthetic psilocybin (which has it’s downsides) or whole dried mushrooms (also, has downsides). But what if there was a third option that took the best attributes of both? In this episode of The Mushroom Show, we are touring a facility in Vancouver that is developing a standardized version of psilocybin from whole mushrooms which contains all of the secondary metabolites. Is this the future of psilocybin therapy?

Source: Youtube.com

General Inquiries


Investor Relations